{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T11:26:52Z","timestamp":1794742012218,"version":"4.9.1"},"reference-count":122,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T00:00:00Z","timestamp":1627516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: CardioOncology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jaccao.2021.06.007","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T18:28:39Z","timestamp":1632248919000},"page":"343-359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":214,"title":["Past, Present, and Future of Radiation-Induced Cardiotoxicity: Refinements in Targeting, Surveillance, and Risk Stratification"],"prefix":"10.1016","volume":"3","author":[{"given":"Carmen","family":"Bergom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea K.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Samson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1177-8761","authenticated-orcid":false,"given":"Juan","family":"Lopez-Mattei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaccao.2021.06.007_bib1","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/cncr.21324","article-title":"The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines","volume":"104","author":"Delaney","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.jaccao.2021.06.007_bib2","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaccao.2021.06.007_bib3","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1200\/JCO.2016.69.8480","article-title":"Validation and modification of a prediction model for acute cardiac events in patients with breast cancer treated with radiotherapy based on three-dimensional dose distributions to cardiac substructures","volume":"35","author":"van den Bogaard","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib4","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1200\/JCO.2016.72.0722","article-title":"Estimating the risks of breast cancer radiotherapy: evidence from modern radiation doses to the lungs and heart and from previous randomized trials","volume":"35","author":"Taylor","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.radonc.2017.10.001","article-title":"Heart dosimetric analysis of three types of cardiac toxicity in patients treated on dose-escalation trials for stage III nonsmall-cell lung cancer","volume":"125","author":"Wang","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib6","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1200\/JCO.2016.71.6142","article-title":"Cardiac events after radiation therapy: combined analysis of prospective multicenter trials for locally advanced non\u2013small-cell lung cancer","volume":"35","author":"Dess","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.radonc.2014.11.037","article-title":"Is cardiac toxicity a relevant issue in the radiation treatment of esophageal cancer?","volume":"114","author":"Beukema","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib8","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1016\/j.jacc.2019.03.500","article-title":"Cardiac radiation dose, cardiac disease, and mortality in patients with lung cancer","volume":"73","author":"Atkins","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejca.2017.07.053","article-title":"Radiation dose to heart base linked with poorer survival in lung cancer patients","volume":"85","author":"McWilliam","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jaccao.2021.06.007_bib10","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.radonc.2017.04.017","article-title":"Dose to heart substructures is associated with noncancer death after SBRT in stage I-II NSCLC patients","volume":"123","author":"Stam","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib11","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/jrr\/rraa001","article-title":"Analysis of cardiac toxicity after definitive chemoradiotherapy for esophageal cancer using a biological dose-volume histogram","volume":"61","author":"Takeuchi","year":"2020","journal-title":"J\u00a0Radiat Res"},{"key":"10.1016\/j.jaccao.2021.06.007_bib12","first-page":"7389","article-title":"Risk factors for pericardial effusion in patients with stage i esophageal cancer treated with chemoradiotherapy","volume":"34","author":"Tamari","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jaccao.2021.06.007_bib13","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ijrobp.2007.10.056","article-title":"Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy","volume":"70","author":"Wei","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jaccao.2021.06.007_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijrobp.2014.01.021","article-title":"Prospective coronary heart disease screening in asymptomatic Hodgkin lymphoma patients using coronary computed tomography angiography: results and risk factor analysis","volume":"89","author":"Girinsky","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jaccao.2021.06.007_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv008","article-title":"Risk of valvular heart disease after treatment for Hodgkin lymphoma","volume":"107","author":"Cutter","year":"2015","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jaccao.2021.06.007_bib16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13014-017-0772-5","article-title":"Is pulmonary artery a dose-limiting organ at risk in nonsmall cell lung cancer patients treated with definitive radiotherapy?","volume":"12","author":"Ma","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ijrobp.2014.02.011","article-title":"Pulmonary artery invasion, high-dose radiation, and overall survival in patients with nonsmall cell lung cancer","volume":"89","author":"Han","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jaccao.2021.06.007_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijrobp.2017.04.026","article-title":"The impact of cardiac radiation dosimetry on survival after radiation therapy for non-small cell lung cancer","volume":"99","author":"Vivekanandan","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jaccao.2021.06.007_bib19","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.radonc.2011.08.040","article-title":"Dosimetric predictors of asymptomatic heart valvular dysfunction following mediastinal irradiation for Hodgkin\u2019s lymphoma","volume":"101","author":"Cella","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10549-018-5053-y","article-title":"Evaluation of radiation-induced cardiac toxicity in breast cancer patients treated with trastuzumab-based chemotherapy","volume":"174","author":"Abouegylah","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jaccao.2021.06.007_bib21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13014-019-1242-z","article-title":"The relationship between radiation doses to coronary arteries and location of coronary stenosis requiring intervention in breast cancer survivors","volume":"14","author":"Wennstig","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib22","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.jtho.2018.05.028","article-title":"Dosimetric predictors of symptomatic cardiac events after conventional-dose chemoradiation therapy for inoperable NSCLC","volume":"13","author":"Yegya-Raman","year":"2018","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib23","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.radonc.2015.07.043","article-title":"Coronary stenosis risk analysis following Hodgkin lymphoma radiotherapy: a study based on patient specific artery segments dose calculation","volume":"117","author":"Moignier","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib24","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/ejhf.1376","article-title":"The role of irradiated heart and left ventricular volumes in heart failure occurrence after childhood cancer","volume":"21","author":"Mansouri","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jaccao.2021.06.007_bib25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.canrad.2014.01.001","article-title":"Potential impact of cardiac dose-volume on acute cardiac toxicity following concurrent trastuzumab and radiotherapy","volume":"18","author":"Cao","year":"2014","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.jaccao.2021.06.007_bib26","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/pbc.25381","article-title":"Prospective cardiac MRI for the analysis of biventricular function in children undergoing cancer treatments","volume":"62","author":"de Ville de Goyet","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jaccao.2021.06.007_bib27","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.1016\/j.cllc.2017.08.002","article-title":"Survival impact of cardiac dose following lung stereotactic body radiotherapy","volume":"19","author":"Wong","year":"2018","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.jaccao.2021.06.007_bib28","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/jamaoncol.2020.6332","article-title":"Association of left anterior descending coronary artery radiation dose with major adverse cardiac events and mortality in patients with non\u2013small cell lung cancer","volume":"7","author":"Atkins","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib29","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1634\/theoncologist.2014-0299","article-title":"Diastolic dysfunction occurs early in HER2-positive breast cancer patients treated concurrently with radiation therapy and trastuzumab","volume":"20","author":"Cao","year":"2015","journal-title":"Oncologist"},{"key":"10.1016\/j.jaccao.2021.06.007_bib30","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.hrthm.2020.03.013","article-title":"Cardiac radioablation\u2014a systematic review","volume":"17","author":"van der Ree","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jaccao.2021.06.007_bib31","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1200\/JCO.2010.29.9362","article-title":"Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study","volume":"28","author":"Haugnes","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib32","first-page":"5","article-title":"Evidence for a tumoricidal dose level in the radiotherapy of Hodgkin\u2019s disease","volume":"26","author":"Kaplan","year":"1966","journal-title":"Cancer Rese"},{"key":"10.1016\/j.jaccao.2021.06.007_bib33","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/cncr.2820690528","article-title":"Coronary artery disease mortality in patients treated for Hodgkin\u2019s disease","volume":"69","author":"Boivin","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.jaccao.2021.06.007_bib34","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1001\/jama.1993.03510160067031","article-title":"Factors affecting late mortality from heart disease after treatment of Hodgkin\u2019s disease","volume":"270","author":"Hancock","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.jaccao.2021.06.007_bib35","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1182\/blood-2010-06-291328","article-title":"Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation","volume":"117","author":"Galper","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaccao.2021.06.007_bib36","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jamainternmed.2015.1180","article-title":"Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk","volume":"175","author":"van Nimwegen","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jaccao.2021.06.007_bib37","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/pbc.22664","article-title":"Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies","volume":"55","author":"Schellong","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jaccao.2021.06.007_bib38","doi-asserted-by":"crossref","first-page":"b4606","DOI":"10.1136\/bmj.b4606","article-title":"Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort","volume":"339","author":"Mulrooney","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jaccao.2021.06.007_bib39","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S1470-2045(16)30215-7","article-title":"Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin\u2019s lymphoma: an analysis from the St Jude Lifetime Cohort Study","volume":"17","author":"Bhakta","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib40","doi-asserted-by":"crossref","first-page":"e492","DOI":"10.1016\/S2352-3026(15)00153-2","article-title":"Cardiovascular disease after treatment for Hodgkin\u2019s lymphoma: an analysis of nine collaborative EORTC-LYSA trials","volume":"2","author":"Maraldo","year":"2015","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib41","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1200\/JCO.2015.63.4444","article-title":"Radiation dose-response relationship for risk of coronary heart disease in survivors of Hodgkin lymphoma","volume":"34","author":"van Nimwegen","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib42","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1182\/blood-2016-09-740332","article-title":"Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines","volume":"129","author":"van Nimwegen","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jaccao.2021.06.007_bib43","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ijrobp.2013.05.005","article-title":"Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the International Lymphoma Radiation Oncology Group (ILROG)","volume":"89","author":"Specht","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jaccao.2021.06.007_bib44","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.ijrobp.2020.03.019","article-title":"Involved site radiation therapy in adult lymphomas: an overview of International Lymphoma Radiation Oncology Group guidelines","volume":"107","author":"Wirth","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jaccao.2021.06.007_bib45","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1259\/bjr\/86221320","article-title":"The physical basis and future of radiation therapy","volume":"84","author":"Bortfeld","year":"2011","journal-title":"Br J Radiol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib46","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1200\/JCO.2007.15.1001","article-title":"Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin\u2019s lymphoma: a question of field size","volume":"26","author":"Campbell","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib47","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijrobp.2011.05.054","article-title":"Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy","volume":"83","author":"Koeck","year":"2012","journal-title":"Int J Radiat Oncol. Biol Phys"},{"key":"10.1016\/j.jaccao.2021.06.007_bib48","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.ijrobp.2011.09.020","article-title":"Risk of developing cardiovascular disease after involved node radiotherapy versus mantle field for Hodgkin lymphoma","volume":"83","author":"Maraldo","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jaccao.2021.06.007_bib49","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1748-717X-9-94","article-title":"Dosimetric advantages of a \u201cbutterfly\u201d technique for intensity-modulated radiation therapy for young female patients with mediastinal Hodgkin\u2019s lymphoma","volume":"9","author":"Voong","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib50","doi-asserted-by":"crossref","first-page":"l6794","DOI":"10.1136\/bmj.l6794","article-title":"Major cardiac events for adult survivors of childhood cancer diagnosed between 1970 and 1999: report from the Childhood Cancer Survivor Study cohort","volume":"368","author":"Mulrooney","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jaccao.2021.06.007_bib51","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1200\/JCO.18.01764","article-title":"Therapy-related cardiac risk in childhood cancer survivors: an analysis of the Childhood Cancer Survivor Study","volume":"37","author":"Bates","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib52","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1200\/JCO.2010.33.4730","article-title":"High risk of symptomatic cardiac events in childhood cancer survivors","volume":"30","author":"van der Pal","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib53","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/heartjnl-2020-316655","article-title":"Increased risk of cardiac ischaemia in a pan-European cohort of 36 205 childhood cancer survivors: a PanCareSurFup study","volume":"107","author":"Feijen","year":"2021","journal-title":"Heart"},{"key":"10.1016\/j.jaccao.2021.06.007_bib54","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1161\/CIR.0b013e3182a88099","article-title":"Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: A scientific statement from the American Heart Association","volume":"128","author":"Lipshultz","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2021.06.007_bib55","doi-asserted-by":"crossref","first-page":"e387","DOI":"10.1542\/peds.2007-0575","article-title":"Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children\u2019s Oncology Group","volume":"121","author":"Shankar","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaccao.2021.06.007_bib56","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/S1470-2045(14)70409-7","article-title":"Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group","volume":"16","author":"Armenian","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib57","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","article-title":"Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials","volume":"366","author":"Clarke","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jaccao.2021.06.007_bib58","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.ijrobp.2015.11.040","article-title":"Cardiovascular disease risk in a large, population-based cohort of breast cancer survivors","volume":"94","author":"Boekel","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jaccao.2021.06.007_bib59","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/S0140-6736(19)32514-0","article-title":"Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial","volume":"394","author":"Vicini","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaccao.2021.06.007_bib61","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/1754-9485.12804","article-title":"Contouring consensus guidelines in breast cancer radiotherapy: comparison and systematic review of patterns of failure","volume":"63","author":"Gee","year":"2019","journal-title":"J\u00a0Med Imaging. Radiat Oncol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib62","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev-med-042716-103422","article-title":"Novel radiotherapy techniques for breast cancer","volume":"69","author":"Bradley","year":"2018","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jaccao.2021.06.007_bib63","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ijrobp.2018.10.025","article-title":"Radiation dose-response for risk of myocardial infarction in breast cancer survivors","volume":"103","author":"Jacobse","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jaccao.2021.06.007_bib64","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.prro.2019.01.004","article-title":"Cardiac structure doses in women irradiated for breast cancer in the past and their use in epidemiological studies","volume":"9","author":"Duane","year":"2019","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00066-018-1378-z","article-title":"Heart toxicity from breast cancer radiotherapy: current findings, assessment, and prevention","volume":"195","author":"Piroth","year":"2019","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib66","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/COC.0000000000000573","article-title":"Cardiac toxicity in operable esophageal cancer patients treated with or without chemoradiation","volume":"42","author":"Witt","year":"2019","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib67","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1200\/JCO.2016.69.1378","article-title":"Impact of intensity-modulated radiation therapy technique for locally advanced non\u2013small-cell lung cancer: a secondary analysis of the NRG Oncology RTOG 0617 randomized clinical trial","volume":"35","author":"Chun","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib68","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijrobp.2008.10.075","article-title":"Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma","volume":"75","author":"Morota","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jaccao.2021.06.007_bib69","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1080\/14779072.2018.1538785","article-title":"Radiation and the heart: systematic review of dosimetry and cardiac end points","volume":"16","author":"Niska","year":"2018","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.jaccao.2021.06.007_bib70","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.ctrv.2013.03.005","article-title":"Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: a systematic review of incidence, manifestations and predisposing factors","volume":"39","author":"Polk","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jaccao.2021.06.007_bib71","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","volume":"16","author":"Bradley","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib72","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1200\/JCO.2016.70.0229","article-title":"Cardiac toxicity after radiotherapy for stage III non\u2013small-cell lung cancer: pooled analysis of dose-escalation trials delivering 70 to 90 Gy","volume":"35","author":"Wang","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib73","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.21037\/jtd.2018.04.42","article-title":"Cardiac radiation dose distribution, cardiac events and mortality in early-stage lung cancer treated with stereotactic body radiation therapy (SBRT)","volume":"10","author":"Reshko","year":"2018","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.jaccao.2021.06.007_bib74","doi-asserted-by":"crossref","first-page":"93","DOI":"10.7326\/M15-0424","article-title":"Cardiac outcomes in adult survivors of childhood cancer exposed to cardiotoxic therapy: a cross-sectional study from the St. Jude Lifetime Cohort","volume":"164","author":"Mulrooney","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaccao.2021.06.007_bib75","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/djk064","article-title":"Long-term risk of cardiovascular disease in 10-year survivors of breast cancer","volume":"99","author":"Hooning","year":"2007","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jaccao.2021.06.007_bib76","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.radonc.2013.10.029","article-title":"Atherosclerotic lesions in lymphoma survivors treated with radiotherapy","volume":"110","author":"Wethal","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib77","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1200\/JCO.2013.49.3205","article-title":"Modifiable risk factors and major cardiac events among adult survivors of childhood cancer","volume":"31","author":"Armstrong","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib78","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jama.2012.9624","article-title":"Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals","volume":"308","author":"Yeboah","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jaccao.2021.06.007_bib79","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.radonc.2017.10.009","article-title":"Is the coronary artery calcium score associated with acute coronary events in breast cancer patients treated with radiotherapy?","volume":"126","author":"Roos","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib80","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1161\/CIRCIMAGING.113.000092","article-title":"Validation and prognosis of coronary artery calcium scoring in nontriggered thoracic computed tomography: systematic review and meta-analysis","volume":"6","author":"Xie","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jaccao.2021.06.007_bib81","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/ehjci\/jet123","article-title":"Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography","volume":"14","author":"Lancellotti","year":"2013","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jaccao.2021.06.007_bib82","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","article-title":"Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline","volume":"35","author":"Armenian","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib83","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.annonc.2019.10.023","article-title":"Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations","volume":"31","author":"Curigliano","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib84","first-page":"360","article-title":"Cardiovascular manifestations from therapeutic radiation: a multidisciplinary expert consensus statement from the international cardio-oncology society","volume":"3","author":"Mitchell","year":"2021","journal-title":"J Am Coll Cardiol CardioOnc"},{"key":"10.1016\/j.jaccao.2021.06.007_bib86","first-page":"655","article-title":"How to diagnose and manage radiation cardiotoxicity","volume":"2","author":"Ganatra","year":"2020","journal-title":"J Am Coll Cardiol CardioOnc"},{"key":"10.1016\/j.jaccao.2021.06.007_bib87","article-title":"Long-term outcomes of patients with mediastinal radiation-associated severe aortic stenosis and subsequent surgical aortic valve replacement: a matched cohort study","volume":"6","author":"Donnellan","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jaccao.2021.06.007_bib88","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/jocs.14427","article-title":"Outcomes of cardiac surgery after mediastinal radiation therapy: a single-center experience","volume":"35","author":"Dolmaci","year":"2020","journal-title":"J\u00a0Card Surg"},{"key":"10.1016\/j.jaccao.2021.06.007_bib89","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1415340","article-title":"Regional nodal irradiation in early-stage breast cancer","volume":"373","author":"Whelan","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaccao.2021.06.007_bib90","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1161\/CIRCULATIONAHA.116.025434","article-title":"Risk of heart failure with preserved ejection fraction in older women after contemporary radiotherapy for breast cancer","volume":"135","author":"Saiki","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2021.06.007_bib91","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1200\/JCO.2006.07.0805","article-title":"Screening for coronary artery disease after mediastinal irradiation for Hodgkin\u2019s disease","volume":"25","author":"Heidenreich","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib92","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s10554-016-0837-9","article-title":"Detection of radiotherapy-induced myocardial changes by ultrasound tissue characterisation in patients with breast cancer","volume":"32","author":"Tuohinen","year":"2016","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.jaccao.2021.06.007_bib93","first-page":"2141","article-title":"Early effects of adjuvant breast cancer radiotherapy on right ventricular systolic and diastolic function","volume":"35","author":"Tuohinen","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jaccao.2021.06.007_bib94","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.radonc.2018.10.023","article-title":"Persistent reduction in global longitudinal strain in the longer term after radiation therapy in patients with breast cancer","volume":"132","author":"Trivedi","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib95","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.jtcvs.2015.01.045","article-title":"Impact of long-axis function on cardiac surgical outcomes in patients with radiation-associated heart disease","volume":"149","author":"Chirakarnjanakorn","year":"2015","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jaccao.2021.06.007_bib96","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s13014-019-1408-8","article-title":"Early detection of subclinical left ventricular dysfunction after breast cancer radiation therapy using speckle-tracking echocardiography: association between cardiac exposure and longitudinal strain reduction (BACCARAT study)","volume":"14","author":"Walker","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib97","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.athoracsur.2013.12.029","article-title":"Increased aorto-mitral curtain thickness independently predicts mortality in patients with radiation-associated cardiac disease undergoing cardiac surgery","volume":"97","author":"Desai","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jaccao.2021.06.007_bib98","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1200\/JCO.2011.40.3584","article-title":"Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging","volume":"30","author":"Armstrong","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib99","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJM200011163432003","article-title":"The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction","volume":"343","author":"Kim","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaccao.2021.06.007_bib100","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12968-016-0308-4","article-title":"Cardiac T1 mapping and extracellular volume (ECV) in clinical practice: a comprehensive review","volume":"18","author":"Haaf","year":"2016","journal-title":"J\u00a0Cardiovasc Magn Reason"},{"key":"10.1016\/j.jaccao.2021.06.007_bib101","doi-asserted-by":"crossref","first-page":"142","DOI":"10.14797\/mdcj-9-3-142","article-title":"The role of cardiac magnetic resonance in valvular heart disease","volume":"9","author":"Lopez-Mattei","year":"2013","journal-title":"Methodist DeBakey Cardiovasc J"},{"key":"10.1016\/j.jaccao.2021.06.007_bib102","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/CRD.0b013e318197e950","article-title":"The utility of cardiovascular magnetic resonance in constrictive pericardial disease","volume":"17","author":"Ariyarajah","year":"2009","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.jaccao.2021.06.007_bib103","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0046-8177(96)90447-5","article-title":"Pathology of radiation-induced heart disease: a surgical and autopsy study of 27 cases","volume":"27","author":"Veinot","year":"1996","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib104","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jacc.2013.07.076","article-title":"Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making","volume":"62","author":"Gould","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib105","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0360-3016(00)01531-5","article-title":"Cardiac perfusion changes in patients treated for breast cancer with radiation therapy and doxorubicin: preliminary results","volume":"49","author":"Hardenbergh","year":"2001","journal-title":"Int J Radiat Oncol Biol Phy.s"},{"key":"10.1016\/j.jaccao.2021.06.007_bib106","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1002\/cncr.22965","article-title":"Prospective assessment of radiotherapy-associated cardiac toxicity in breast cancer patients: analysis of data 3 to 6 years after treatment","volume":"110","author":"Prosnitz","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.jaccao.2021.06.007_bib107","first-page":"1756","article-title":"The prevalence of myocardial ischemia after concurrent chemoradiation therapy as detected by gated myocardial perfusion imaging in patients with esophageal cancer","volume":"47","author":"Gayed","year":"2006","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jaccao.2021.06.007_bib108","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10554-009-9440-7","article-title":"The clinical implications of myocardial perfusion abnormalities in patients with esophageal or lung cancer after chemoradiation therapy","volume":"25","author":"Gayed","year":"2009","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.jaccao.2021.06.007_bib109","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11864-019-0645-2","article-title":"Applications of cardiac computed tomography in the cardio-oncology population","volume":"20","author":"Layoun","year":"2019","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib110","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4250\/jcvi.2019.27.e38","article-title":"Coronary artery dose-volume parameters predict risk of calcification after radiation therapy","volume":"27","author":"Milgrom","year":"2019","journal-title":"J.\u00a0Cardiovasc. Imaging"},{"key":"10.1016\/j.jaccao.2021.06.007_bib111","doi-asserted-by":"crossref","first-page":"223","DOI":"10.21037\/jtd.2020.01.52","article-title":"Heart dose and coronary artery calcification in patients receiving thoracic irradiation for lung cancer","volume":"12","author":"Yakupovich","year":"2020","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.jaccao.2021.06.007_bib112","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ijcard.2019.01.103","article-title":"Could coronary calcification identified at nongated chest CT be a predictor for cardiovascular events in breast cancer patients?","volume":"282","author":"Tomizawa","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib113","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1016\/j.jacc.2018.09.051","article-title":"Impact of statins on cardiovascular outcomes following coronary artery calcium scoring","volume":"72","author":"Mitchell","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib114","first-page":"135","article-title":"Incidental coronary artery calcification in cancer imaging","volume":"1","author":"Cuddy","year":"2019","journal-title":"J\u00a0Am Coll Cardiol CardioOnc"},{"key":"10.1016\/j.jaccao.2021.06.007_bib115","first-page":"12","article-title":"Reporting of coronary artery calcification on chest CT studies in breast cancer patients at high risk of cancer therapy related cardiac events","volume":"18","author":"Phillips","year":"2018","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.jaccao.2021.06.007_bib116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167925","article-title":"Automatic coronary artery calcium scoring on radiotherapy planning CT scans of breast cancer patients: reproducibility and association with traditional cardiovascular risk factors","volume":"11","author":"Gernaat","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jaccao.2021.06.007_bib117","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.ijrobp.2011.08.012","article-title":"Preradiotherapy calcium scores of the coronary arteries in a cohort of women with early-stage breast cancer: a comparison with a cohort of healthy women","volume":"83","author":"Mast","year":"2012","journal-title":"Int J Radiat Oncol Biol Phy.s"},{"key":"10.1016\/j.jaccao.2021.06.007_bib118","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.ijrobp.2018.11.013","article-title":"Early changes in cardiovascular biomarkers with contemporary thoracic radiation therapy for\u00a0breast cancer, lung cancer, and lymphoma","volume":"103","author":"Demissei","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jaccao.2021.06.007_bib119","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.ijrobp.2019.04.002","article-title":"Lipopolysaccharide-binding protein is an early biomarker of cardiac function after radiation therapy for breast cancer","volume":"104","author":"Chalubinska-Fendler","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jaccao.2021.06.007_bib120","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/cncr.33292","article-title":"Cardiac\u00a0biomarkers and association with subsequent cardiomyopathy and mortality among adult survivors of childhood cancer: a report from the\u00a0St. Jude Lifetime Cohort","volume":"127","author":"Dixon","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.jaccao.2021.06.007_bib121","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.hrthm.2018.04.015","article-title":"Safety and efficacy of stereotactic radioablation targeting pulmonary vein tissues in an experimental model","volume":"15","author":"Zei","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jaccao.2021.06.007_bib122","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004304","article-title":"External arrhythmia ablation using photon beams: ablation of the atrioventricular junction in an intact animal model","volume":"10","author":"Lehmann","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jaccao.2021.06.007_bib123","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/CIRCULATIONAHA.118.038261","article-title":"Phase I\/II trial of electrophysiology-guided noninvasive cardiac radioablation for ventricular tachycardia","volume":"139","author":"Robinson","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2021.06.007_bib124","article-title":"Cardiac function after noninvasive radioablation [abstract]","author":"Hall","year":"2019","journal-title":"Heart Rhythm Society Annual Meeting"}],"container-title":["JACC: CardioOncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087321001587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087321001587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T18:54:13Z","timestamp":1762973653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666087321001587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":122,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S2666087321001587"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccao.2021.06.007","relation":{},"ISSN":["2666-0873"],"issn-type":[{"value":"2666-0873","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Past, Present, and Future of Radiation-Induced Cardiotoxicity: Refinements in Targeting, Surveillance, and Risk Stratification","name":"articletitle","label":"Article Title"},{"value":"JACC: CardioOncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccao.2021.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}